Domestic API firms revenue to see 7-8 percent rise by 2029: Icra Ruchika Sharma14 Aug 2024 2:30 PM ISTNew Delhi: The revenue of domestic active pharmaceutical ingredient (API) manufacturing firms is projected to grow by 7-8 percent by 2029, according...
Aggregate occupancy of hospitals to remain strong at 61-63 per cent in FY2025: ICRA Kajal Rajput9 Aug 2024 2:45 PM ISTNew Delhi: Rating agency ICRA expects the aggregate occupancy for its hospital industry's sample set companies to remain strong at 61-63% in FY2025...
Private hospital chains to add over 30K beds at an investment of Rs 32,500 crore in 4-5 years: ICRA Kajal Rajput19 Jan 2024 1:30 PM ISTNew Delhi: Private hospital chains are expected to add over 30,000 beds at an investment of Rs 32,500 crore in the country over the next four to five...
Revenue of 25 leading domestic pharma cos expected to grow 9-11 percent in current fiscal year: ICRA Ruchika Sharma5 Jan 2024 12:30 PM ISTNew Delhi: Revenue of 25 leading domestic pharmaceutical companies is expected to grow 9-11 per cent in the current fiscal year, as per Icra.The...
Indian Hospital Industry saw private equity deals worth over Rs 27000 crore in last two years: ICRA Ruchika Sharma16 Aug 2023 5:38 PM ISTNew Delhi: The Indian hospital industry is expected to remain strong in the coming year, with a projected aggregate occupancy rate of 63-65% and...
Top domestic pharmaceutical firms revenue to grow by 7-9 percent in FY24: Icra Ruchika Sharma26 July 2023 1:30 PM ISTIcra said that a continued focus on complex generics/speciality launches in the US market is expected to support industry margins in FY2024.
Domestic pharma industry revenues expected to grow 6-8 percent next fiscal: Rating agency ICRA Ruchika Sharma18 March 2023 10:00 AM ISTIn terms of emerging trends in the industry, e-pharmacies have gained significant traction in recent years and now account for 10-15 percent of the...
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Persisting cost inflation, pricing pressures impact pharma industry, minimal impact of European market headwinds thus far: ICRA Ruchika Sharma2 Nov 2022 1:30 PM ISTNew Delhi: ICRA's sample set of 16 Indian pharmaceutical companies registered revenue growth of 4.9% YoY in Q1 FY2023. This was supported by 4.2%...
Indian Pharma firms likely to see muted revenue growth from US Generics Market in FY23: Ratings agency Icra Ruchika Sharma28 July 2022 3:34 PM ISTNew Delhi: Indian pharmaceutical firms are likely to witness muted revenue growth from the US generics market in FY23 due to price erosion pressure,...
Hospital industry revenue growth to moderate in FY2023: ICRA Ruchika Sharma21 April 2022 2:58 PM ISTNew Delhi: The performance of ICRA's sample set of hospital companies remained strong in Q3 FY2022 on the back of continued momentum of elective...
Revenues of domestic pharma companies projected to grow by 6-8 percent in FY23: Ratings firm ICRA Ruchika Sharma8 April 2022 9:30 AM ISTNew Delhi: Revenues of leading domestic pharma companies are likely to grow by 6-8 per cent in the current fiscal, ratings firm Icra said on Thursday....
